Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating JNJ-77242113 for moderate-to-severe plaque psoriasis. The snippet does not provide efficacy o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• JNJ-77242113

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED